Bleeding risk scores in cancer patients: new AI and ML tools
The integration of artificial intelligence (AI) into clinical research has transformed how medical data is analyzed,...
LATEST ARTICLES
Thrombocytopenia and management of anticoagulation in the patient with thrombosis and cancer
Cancer-associated thrombosis (CAT) presents a unique and multifaceted challenge in clinical practice, particularly in...
The Combined Impact of Serum Albumin and Genetic Risk on VTE: Implications for Early Prevention
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most...
Heparin-Induced Thrombocytopenia: The Expanding Role of Factor Xa Inhibitors in Therapy
Heparin products, such as unfractionated heparin and low-molecular-weight heparin (LMWH), are commonly employed as...
An Overview of VTE Prevention and Management in Gynecological Cancer Care
As with cancers in general, gynecological cancers also exhibit a clear and increasingly significant association with...
Thromboprophylaxis in Portuguese Cancer Outpatients: Real-World Insights and Patient Characterization
Venous thromboembolism (VTE) affects up to 20% of cancer patients, presenting a four-to-seven-fold increased risk...